← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▼ SELL

$ Value

$3K

Shares

2,858

Price

$1

Filed

Jan 7

Insider

Name

Prior Stephen David

Title

Chief Strategy Officer

CIK

0002042268

Roles

Officer

Transaction Details

Transaction Date

2026-01-06

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

59,086

Footnotes

Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2026. | Includes (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, (b) a balance of 17,500 RSUs which shall continue to vest as originally approved through December 31, 2024. On January 1, 2025, 1/3 of the remaining RSUs (rounded down to the nearest whole number of shares) shall vest and all remaining unvested RSUs shall vest on January 1, 2026; and (c) 28,000 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.

Filing Info

Accession No.

0001193125-26-006770

Form Type

4

Issuer CIK

0001880438

Prior Stephen David's History

Date Ticker Type Value
2026-01-06 ANTX $3K
2026-01-05 ANTX $4K
2025-11-04 ANTX $872

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03